The Mobile Insulin Titration Intervention (MITI) for Insulin Glargine Titration in an Urban, Low-Income Population: Randomized Controlled Trial Protocol

JMIR Research Protocols
Natalie LevySundar Natarajan

Abstract

Patients on insulin glargine typically visit a clinician to obtain advice on how to adjust their insulin dose. These multiple clinic visits can be costly and time-consuming, particularly for low-income patients. It may be feasible to achieve insulin titration through text messages and phone calls with patients instead of face-to-face clinic visits. The objectives of this study are to (1) evaluate if the Mobile Insulin Titration Intervention (MITI) is clinically effective by helping patients reach their optimal dose of insulin glargine, (2) determine if the intervention is feasible within the setting and population, (3) assess patient satisfaction with the intervention, and (4) measure the costs associated with this intervention. This is a pilot study evaluating an approach to insulin titration using text messages and phone calls among patients with insulin-dependent type 2 diabetes in the outpatient medical clinic of Bellevue Hospital Center, a safety-net hospital in New York City. Patients will be randomized in a 1:1 ratio to either the MITI arm (texting/phone call intervention) or the usual-care arm (in-person clinic visits). Using a Web-based platform, weekday text messages will be sent to patients in the MITI arm, asking th...Continue Reading

Associated Clinical Trials

Jun 18, 2013·Natalie Levy, Natalie Levy

References

May 24, 2007·Journal of Clinical Nursing·Hee-Seung Kim, Hye-Sun Jeong
Feb 6, 2008·BMC Health Services Research·Enza GucciardiDonna E Stewart
Aug 16, 2011·Diabetes Research and Clinical Practice·Wiam I HusseinAhmed A Jaradat
Oct 27, 2011·Journal of Diabetes Science and Technology·Jonathan J DickMonica E Peek
Jan 3, 2012·Journal of Medical Internet Research·Gunther Eysenbach, UNKNOWN CONSORT-EHEALTH Group
May 10, 2012·Diabetes Technology & Therapeutics·Richard M BergenstalIsrael Hodish
Dec 12, 2012·Journal of the American Pharmacists Association : JAPhA·Emily Weidman-EvansAshley Fort

❮ Previous
Next ❯

Citations

Jun 22, 2016·Journal of Diabetes Science and Technology·Andreas PfütznerDiethelm Tschoepe
Feb 26, 2016·Current Opinion in Endocrinology, Diabetes, and Obesity·Daniel J Amante, Michael J Thompson

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01879579

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.